title: Liver transplant and chronic hepatitis B virus infection.
abstract: Hepatitis B immune globulin use for preventing hepatitis B virus recurrence after liver transplant has changed our behavior radically, and it now seems that hepatitis B immune globulin has a vital role in preventing recurrence. New nucleotide or nucleoside analogues have promising results in treating chronic hepatitis and in posttransplant hepatitis B virus-infected patients. Hepatitis B immune globulin and other antivirals act on different pathways, so it is logical to combine these drugs to achieve maximum response in suppressing hepatitis B virus (HBV)-replication.
authors: Department of Gastroenterology, Baskent University Faculty of Medicine, Ankara, Turkey.
authors: Haldun
authors: H
authors: Selcuk
authors: Hamdi
authors: H
authors: Karakayali
authors: Mehmet
authors: M
authors: Haberal
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007136:Immunoglobulins / Q000494:pharmacology / Q000627:therapeutic use*; D016031:Liver Transplantation; D012008:Recurrence; D014779:Virus Replication / Q000187:drug effects / Q000502:physiology
chemical_list: D000998:Antiviral Agents; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin